Roche’s Genentech unit has tapped Cour to help develop and commercialize the biotech’s bespoke tolerogenic nanoparticle treatments for autoimmune diseases, Cour said Tuesday. Under the deal ...

Roche signed a definitive agreement to acquire Poseida Therapeutics, a deal that includes Poseida’s portfolio of CAR T-cell therapy candidates being developed for multiple sclerosis (MS) and ...

When Mike Bucher and his partners bought the old Blitch Knevel Architects building at the corner of Julia Street and St. Charles Avenue in 2021, they thought about converting the historic ...

Pharmaceutical giant Roche has agreed to buy San Diego-based Poseida Therapeutics for about $1 billion in its effort to assemble a promising pipeline of cell therapies. The merger announced ...